Withdrawal notice to « Patients sous Palbociclib et hormonothérapie pour un cancer du sein métastatique : peut-on prédire la survenue d’une hématotoxicité précoce et sévère ? » [Bull Cancer 108 (2021) 544–552 https://doi.org/10.1016/j.bulcan.2021.01.007]

[Article in French]

Affiliations

¹ Sainte-Catherine Institute, 250, chemin des baigne-pieds, 84000 Avignon, France. Electronic address: lea.vazquez@hotmail.fr.
² Sainte-Catherine Institute, 250, chemin des baigne-pieds, 84000 Avignon, France.

[Article in French]

Léa Vazquez et al. Bull Cancer. 2024 Jan.

. 2024 Jan;111(1):124.

doi: 10.1016/j.bulcan.2023.11.009.

¹ Sainte-Catherine Institute, 250, chemin des baigne-pieds, 84000 Avignon, France. Electronic address: lea.vazquez@hotmail.fr.
² Sainte-Catherine Institute, 250, chemin des baigne-pieds, 84000 Avignon, France.

No abstract available

Retraction of

[Patients treated with palbociclib and endocrine therapy for metastatic breast cancer: Can we predict the occurrence of severe early hematological toxicity?].
Vazquez L, Arnaud A, Grenier J, Debourdeau P. Vazquez L, et al. Bull Cancer. 2021 May;108(5):544-552. doi: 10.1016/j.bulcan.2021.01.007. Epub 2021 Apr 2. Bull Cancer. 2021. Retraction in: Bull Cancer. 2024 Jan;111(1):124. doi: 10.1016/j.bulcan.2023.11.009. PMID: 33820647 Retracted. Review. French.